Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time to time, Senores Pharmaceuticals has informed that the officials of the Company will be attending Investor Conference as on 25th May, 2026.
The above information is a part of company’s filings submitted to BSE.